The ability of acquisition of EMT features in in vitro and in xenograph cells is interpreted as a potential acquired resistance mechanism to sotorasib in the setting of KRAS c.34G > T (p.G12C) mutant NSCLC [196]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.